Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY).
Gibb A, Pirrie SJ, Linton K, Warbey V, Paterson K, Davies AJ, Collins GP, Menne T, McKay P, Fields PA, Miall FM, Nagy E, Wheatley K, Reed R, Baricevic-Jones I, Barrington S, Radford J. Gibb A, et al. Among authors: baricevic jones i. Br J Haematol. 2021 Apr;193(1):63-71. doi: 10.1111/bjh.17073. Epub 2020 Sep 14. Br J Haematol. 2021. PMID: 32926420 Free article. Clinical Trial.
Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?
McDonald S, Reed R, Baricevic-Jones I; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate; Ling S, Plant D, Barton A. McDonald S, et al. Rheumatology (Oxford). 2019 Oct 1;58(10):1872-1873. doi: 10.1093/rheumatology/kez147. Rheumatology (Oxford). 2019. PMID: 31329971 Free PMC article. No abstract available.
Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women.
Njoku K, Pierce A, Geary B, Campbell AE, Kelsall J, Reed R, Armit A, Da Sylva R, Zhang L, Agnew H, Baricevic-Jones I, Chiasserini D, Whetton AD, Crosbie EJ. Njoku K, et al. Among authors: baricevic jones i. Br J Cancer. 2023 May;128(9):1723-1732. doi: 10.1038/s41416-022-02139-0. Epub 2023 Feb 17. Br J Cancer. 2023. PMID: 36807337 Free PMC article.
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus.
Su KYC, Reynolds JA, Reed R, Da Silva R, Kelsall J, Baricevic-Jones I, Lee D, Whetton AD, Geifman N, McHugh N, Bruce IN; the MASTERPLANS and BILAG-BR consortia. Su KYC, et al. Among authors: baricevic jones i. Clin Proteomics. 2023 Jul 29;20(1):29. doi: 10.1186/s12014-023-09420-1. Clin Proteomics. 2023. PMID: 37516862 Free PMC article.
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination.
McGurk KA, Dagliati A, Chiasserini D, Lee D, Plant D, Baricevic-Jones I, Kelsall J, Eineman R, Reed R, Geary B, Unwin RD, Nicolaou A, Keavney BD, Barton A, Whetton AD, Geifman N. McGurk KA, et al. Bioinformatics. 2020 Apr 1;36(7):2217-2223. doi: 10.1093/bioinformatics/btz898. Bioinformatics. 2020. PMID: 31790148 Free PMC article.
RadBone: bone toxicity following pelvic radiotherapy - a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy.
Chatzimavridou Grigoriadou V, Barraclough LH, Baricevic-Jones I, Bristow RG, Eden M, Haslett K, Johnson K, Kochhar R, Merchant Z, Moore J, O'Connell S, Taylor S, Westwood T, Whetton AD, Yorke J, Higham CE. Chatzimavridou Grigoriadou V, et al. Among authors: baricevic jones i. BMJ Open. 2022 Jun 14;12(6):e056600. doi: 10.1136/bmjopen-2021-056600. BMJ Open. 2022. PMID: 35701060 Free PMC article. Clinical Trial.
14 results